Trial site
Woodland Research Northwest
- 7running trials
- 8closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Depression7 trials
- Bipolar disorder5 trials
- Schizophrenia3 trials
- Phase
- Phase 27 trials
- Phase 37 trials
- Phase 11 trial
- Status
- Completed8 trials
- Active, not recruiting4 trials
- Recruiting3 trials
- Lead sponsor
- Xenon Pharmaceuticals Inc.4 trials
- Bristol-Myers Squibb2 trials
- atai Therapeutics, Inc.1 trial
- Beckley Psytech Limited1 trial
- Intra-Cellular Therapies, Inc.1 trial
- and 6 more
Running trials
Active, not recruiting
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
An Open-Label Study of Azetukalner in Major Depressive Disorder
Active, not recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Recruiting
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bipolar disorder2 recruiting
Closed trials
Completed
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Completed
Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients
Completed
Completed
Completed
BPL-003 Efficacy and Safety in Treatment Resistant Depression
Completed
A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia
Completed
A Study of JZP150 in Adults With Posttraumatic Stress Disorder
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026